Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.
Optimizing IFN Beta - 1B Dose (Optims)
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
Ofatumumab
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes.
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Genetics of multiple sclerosis: swimming in an ocean of data.
Race to Erase MS Forum and Expo
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants?
The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis.
Amiloride: a molecular probe of sodium transport in tissues and cells.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Reactive astrocytes as therapeutic targets for CNS disorders.
Good Early Results for HERV Suppressor in MS
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Vitamin D intake and incidence of multiple sclerosis.
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.

Pages